Search
Search Results
##search.searchResults.foundPlural##
-
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1593PDF: 937HTML: 386 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1306PDF: 977HTML: 348 -
FIRST TUNISIAN CLUSTER ADMISSIONS OF CRITICALLY ILL PATIENTS WITH MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) : Multisystem inflammatory syndrome in children (MIS-C)
1480PDF: 567HTML: 233 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1816PDF: 591HTML: 273 -
- KAWASAKI DISEASE AS THE IMMUNE-MEDIATED ECHO OF A VIRAL INFECTION Kawasaki Disease and Viral Infections
1742PDF: 1016HTML: 762 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2703PDF: 1076HTML: 5117Cover Letter: 188Figure 2: 191Figure 1: 197Figure 3: 220Figure 4: 192Figure Legend: 204Table 1: 219Table 2: 205Table 3: 204 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1647PDF: 883HTML: 1082Picture 1: 192 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2795PDF: 1063HTML: 2394 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
212PDF: 691HTML: 66 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1630PDF: 1288HTML: 532 -
Parvovirus B19 infection in a patient with common variable immunodeficiency Parvovirus B19 infection in a patient with common variable immunodeficiency
1155PDF: 431HTML: 307 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1705PDF: 949HTML: 3195Figure 5: 178Figure 4: 176Figure 3: 211Figure 1: 191Figure 2: 190 -
IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES
1090PDF: 662HTML: 275 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2830PDF: 995HTML: 637 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1398PDF: 1011HTML: 500 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
884PDF: 138HTML: 222 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3757PDF: 1270HTML: 5093Incidence age-standardized rates for HL across the Mediterranean basin: 237 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1279PDF: 821HTML: 256 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1399PDF: 787HTML: 414 -
CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY
4506PDF: 1805HTML: 1486Figure 1: Age distribution of Pediatric cases: 244 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1701PDF: 854HTML: 1278Figure 1: 196Figure 2: 210Figure 3: 209 -
Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP. immune thrombocytopenia following mRNA vaccine
2254PDF: 628HTML: 1171







